Ondas's share-funded acquisitions look very risky without a strong core business to make them work. It has raised $1.8B selling shares, yet roughly $1.4B sits in cash and short-term investments. One customer provides 55% of revenue, and $252M plus $742M in stock spent on acquisitions has not produced big revenue; continued raises and management pay add to the concern. x.com 

Ondas has no revenue of its own outside acquired companies, and further buyouts will dilute shareholders. Its 44% short float signals that the market has little faith in it. Shares are headed below $5 and back to penny-stock status before the company performs in the long run. x.com  x.com  x.com  x.com  x.com 

Ondas could have serious upside over the next few years if it delivers anywhere close to the 30%-40% portfolio growth its CEO Eric Brock expects. At current levels, the stock is starting to look compelling. x.com 

Ondas is still a bit early to buy because its story now depends on execution rather than demand, while acquisitions weigh on the shares. Full-year revenue guidance of $525M-$550M implies $390M-$415M in the second half, and the pipeline grew from about $4B to over $11B on European and Asia-Pacific defense deals, but a pipeline only matters once it becomes contracts and deliveries. Q2 carried integration costs and stock compensation; management should pause deals to integrate what it has bought. … Show more

Ondas Holdings' acquisition strategy risks diluting shareholders if revenue cannot catch up with share issuance over a modest period. The model can work if it does; otherwise value gets diluted away. Fair value looks like $3-5. x.com 

Better underwriting at Root, AI data demand at Innodata, defense breadth at Applied Aerospace & Defense, scaled voice AI at SoundHound, more organ access via TransMedics, profitable insurance at Lemonade, autonomous defense at Ondas and successful medicines at AbCellera could drive outsized growth. These eight smaller companies have a realistic path to 5x+ over 5-10 years if they execute on those opportunities. x.com  x.com  x.com  x.com  x.com  x.com  x.com  x.com 

Ondas stock is being suppressed by constant dilution, an acquisition spree and a warrant overhang. It should not break out until the warrant overhang clears; a dip into the mid-$8s could make it worth revisiting. x.com 

Ondas Holdings and Archer Aviation are dead money because endless dilution has outpaced their hot stories. Ondas shareholders haven't made a buck all year as dilution inflates its market cap, and a $460M backlog, even if fully realized, is thin against a roughly $6B market cap. Archer went the same way, climbing on a red-hot story until billions in dilution left enthusiasm unable to keep pace. The biggest cost is opportunity cost in one of the hottest markets of a lifetime. x.com  x.com 

Ondas is a stock being accumulated into its Q1 earnings report, with shares around $9 beforehand and up 12.7% after the results. x.com  x.com  x.com 

Ondas's growth without margin discipline is a warning because it is so far from profitable: its EBITDA loss widened from $10.9M to $50.6M in one quarter. Revenue, orders and defense contracts are real, and guidance rose by $160M, yet the stock fell 8%. x.com